PL3325080T3 - WAYS FOR BETTER DELIVERY OF ACTIVE AGENTS TO TUMORS - Google Patents

WAYS FOR BETTER DELIVERY OF ACTIVE AGENTS TO TUMORS

Info

Publication number
PL3325080T3
PL3325080T3 PL16831139T PL16831139T PL3325080T3 PL 3325080 T3 PL3325080 T3 PL 3325080T3 PL 16831139 T PL16831139 T PL 16831139T PL 16831139 T PL16831139 T PL 16831139T PL 3325080 T3 PL3325080 T3 PL 3325080T3
Authority
PL
Poland
Prior art keywords
tumors
ways
active agents
better delivery
delivery
Prior art date
Application number
PL16831139T
Other languages
Polish (pl)
Inventor
Russell Frederick Ross
Original Assignee
Sorrento Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics, Inc. filed Critical Sorrento Therapeutics, Inc.
Publication of PL3325080T3 publication Critical patent/PL3325080T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PL16831139T 2015-07-24 2016-07-22 WAYS FOR BETTER DELIVERY OF ACTIVE AGENTS TO TUMORS PL3325080T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562196578P 2015-07-24 2015-07-24
US201562196570P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors
EP16831139.7A EP3325080B1 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
PL3325080T3 true PL3325080T3 (en) 2022-01-24

Family

ID=57885141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16831139T PL3325080T3 (en) 2015-07-24 2016-07-22 WAYS FOR BETTER DELIVERY OF ACTIVE AGENTS TO TUMORS

Country Status (15)

Country Link
US (3) US10806913B2 (en)
EP (2) EP3325080B1 (en)
JP (1) JP7082041B2 (en)
KR (1) KR20180035209A (en)
CN (2) CN118902979A (en)
AU (3) AU2016297823B2 (en)
BR (1) BR112018001292A2 (en)
CA (1) CA2991455C (en)
DK (1) DK3325080T3 (en)
ES (1) ES2891523T3 (en)
HU (1) HUE056410T2 (en)
MX (2) MX2018000166A (en)
PL (1) PL3325080T3 (en)
RU (1) RU2719943C2 (en)
WO (1) WO2017019526A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018001292A2 (en) * 2015-07-24 2018-09-11 Kimberly Clark Co methods for better release of active agents to tumors
PL3325081T3 (en) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Methods for lymphatic delivery of active agents
WO2018213579A1 (en) * 2017-05-17 2018-11-22 Massachusetts Institute Of Technology Self-actuating articles
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
WO2019012382A1 (en) 2017-07-10 2019-01-17 Basf Se Mixtures comprising an urease inhibitor (ui) and a nitrification inhibitor such as 2-(3,4-dimethyl-1h-pyrazol-1-yl)succinic acid (dmpsa) or 3,4-dimethyl pyrazolium glycolate (dmpg)
AU2019269636A1 (en) 2018-05-17 2020-11-19 Massachusetts Institute Of Technology Systems for electrical stimulation
AU2019277577A1 (en) * 2018-05-31 2020-12-24 Vivasor, Inc. Drug delivery methods targeting the lymphatic system
WO2020064082A1 (en) * 2018-09-24 2020-04-02 L'oreal Device comprising microneedles for skin-coloring
CN112752590A (en) 2018-09-24 2021-05-04 欧莱雅 Device comprising microneedles for skin in situ reactions
JP2023505231A (en) * 2019-12-05 2023-02-08 ソレント・セラピューティクス・インコーポレイテッド Method for treating cancer by administration of anti-PD-1 or anti-PD-L1 therapeutic agent via lymphatic delivery device
CN117813128A (en) 2021-01-22 2024-04-02 索伦托药业有限公司 Device for microliter lymphatic delivery of coronavirus vaccine
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
US20240279339A1 (en) 2021-06-09 2024-08-22 Vivasor, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
JP2024531337A (en) 2021-08-18 2024-08-29 ソレント・セラピューティクス・インコーポレイテッド Therapeutics that target the lymphatic system
WO2025129128A1 (en) 2023-12-15 2025-06-19 Vivasor, Inc. Compositions and methods for non-viral delivery of therapeutic compounds

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
CN1400897A (en) 2000-06-01 2003-03-05 沃特森药物公司 Transdermal delivery LASOFOXIFENE
AU2002333554C1 (en) * 2001-09-12 2008-12-11 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
AU2004264839B2 (en) * 2003-06-13 2009-06-04 Becton, Dickinson And Company Improved intra-dermal delivery of biologically active agents
AU2004270113A1 (en) 2003-08-26 2005-03-17 Becton, Dickinson And Company Methods for intradermal delivery of therapeutics agents
JP5254616B2 (en) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド Biosynchronous transdermal drug delivery
WO2006127962A2 (en) * 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
EP1893130A4 (en) * 2005-06-17 2015-08-26 Georgia Tech Res Inst COATED MICROSTRUCTURES AND METHOD OF MANUFACTURING THE SAME
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) * 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (en) * 2010-04-27 2012-08-22 上海交通大学 Method for preparing step micro-needle array
JP5860033B2 (en) 2010-04-28 2016-02-16 キンバリー クラーク ワールドワイド インコーポレイテッド Medical devices for siRNA delivery
EP2563455A4 (en) 2010-04-28 2014-02-19 Kimberly Clark Co METHOD FOR INCREASING THE PERMEABILITY OF AN EPITHELIAL BARRIER
CA2797204C (en) 2010-04-28 2018-06-12 Kimberly-Clark Worldwide, Inc. Device for delivery of rheumatoid arthritis medication
MX2012012317A (en) 2010-04-28 2012-11-21 Kimberly Clark Co Injection molded microneedle array and method for forming the microneedle array.
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
CN107058101B (en) * 2011-10-17 2021-06-01 麻省理工学院 intracellular delivery
MX343262B (en) * 2011-10-27 2016-10-28 Kimberly Clark Co Transdermal delivery of high viscosity bioactive agents.
KR101575039B1 (en) * 2012-07-19 2015-12-07 (주)아모레퍼시픽 Nozzle device and minimal invasive injection device comprising the same
EP2895217B1 (en) * 2012-09-13 2020-10-21 Avraham Amir Delivery devices and methods for skin augmentation
CN104884065B (en) * 2012-09-21 2019-01-01 强烈治疗剂公司 The method for the treatment of cancer
CN103157178B (en) * 2013-02-05 2014-12-31 北京化工大学 Seal type tool capable of accurately controlling microneedle insertion length
WO2014132239A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Drug delivery device
WO2014132240A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Transdermal drug delivery device
KR20160004394A (en) 2013-05-23 2016-01-12 킴벌리-클라크 월드와이드, 인크. Microneedles with improved open channel cross-sectional geometries
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
PL3325081T3 (en) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Methods for lymphatic delivery of active agents
BR112018001292A2 (en) * 2015-07-24 2018-09-11 Kimberly Clark Co methods for better release of active agents to tumors

Also Published As

Publication number Publication date
JP2018521755A (en) 2018-08-09
EP3325080A2 (en) 2018-05-30
AU2016297823B2 (en) 2020-10-22
US20240238570A1 (en) 2024-07-18
KR20180035209A (en) 2018-04-05
BR112018001292A2 (en) 2018-09-11
WO2017019526A2 (en) 2017-02-02
DK3325080T3 (en) 2021-10-04
US10806913B2 (en) 2020-10-20
EP3325080A4 (en) 2019-04-17
US20210052871A1 (en) 2021-02-25
CA2991455A1 (en) 2017-02-02
RU2719943C2 (en) 2020-04-23
CA2991455C (en) 2023-10-10
AU2021200146B2 (en) 2022-08-25
CN107921248A (en) 2018-04-17
AU2022275397A1 (en) 2023-01-05
AU2021200146A1 (en) 2021-03-18
JP7082041B2 (en) 2022-06-07
MX2018000166A (en) 2018-03-26
MX2022014277A (en) 2022-12-07
RU2018104102A (en) 2019-08-27
HUE056410T2 (en) 2022-02-28
EP3325080B1 (en) 2021-09-01
EP3925599A1 (en) 2021-12-22
ES2891523T3 (en) 2022-01-28
US20180193624A1 (en) 2018-07-12
RU2018104102A3 (en) 2019-11-06
CN118902979A (en) 2024-11-08
AU2016297823A1 (en) 2018-02-15

Similar Documents

Publication Publication Date Title
CY2024035I1 (en) ANTIBODY COMPOSITIONS FOR TUMOR THERAPY
PL3325080T3 (en) WAYS FOR BETTER DELIVERY OF ACTIVE AGENTS TO TUMORS
IL264901B (en) Administration of kynurenine-reducing enzymes for tumor treatment
SI3350157T1 (en) Compositions for dosing therapeutic agents into cells
PL3377516T3 (en) COMPOSITION FOR TREATMENT OF CANCER
HUE047477T2 (en) Solid dosage forms of Palbociclib
ZA201506916B (en) Microstructure array for delivery of active agents
PL3283527T3 (en) COMBINED TREATMENT OF CANCER
HRP20181679T1 (en) AMID COMPOUNDS FOR THE TREATMENT OF HIV
PL3297605T3 (en) PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE
DK3107563T3 (en) GLYCOM TARGETED THERAPEUTIC AGENTS
KR102494289B9 (en) Active mixture
PL3310904T3 (en) CELLULAR TARGETED ACTIVE SUBSTANCE DELIVERY SYSTEM
LT2968221T (en) PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE
DK3234107T3 (en) B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS
LT2981255T (en) THERAPEUTIC USES OF EMPAGLIFLOZIN
LT3116491T (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICLY ACTIVE COMPOUNDS
PL3186244T3 (en) URIDINE DIOXOLATE ANALOGS IN THE TREATMENT OF CANCER
HRP20190101T1 (en) THERAPEUTIC USES OF EMPAGLIFLOZINE
MA39483A (en) TARGET THERAPEUTIC AGENTS
SI4119569T1 (en) CONJUGATED ANTI-SENSORY COMPOUNDS FOR THERAPEUTIC USE
HUE056424T2 (en) Methods for lymphatic delivery of active agents
IL256206A (en) mct4 inhibitors to treat the disease
DK3363428T3 (en) PERFUSION DOSAGE FORM
HRP20181570T1 (en) DOSAGE MODE OF FGF-18 COMPOUND